Skyward Specialty Insurance Group, Inc.
SKWD Nasdaq Fire, Marine & Casualty Insurance Financials FY2021βFY2025
What Skyward Specialty Insurance Group, Inc. does
No business description yet.
- Legal name
- Skyward Specialty Insurance Group, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0001519449-26-000015
0001519449
Revenue and margins
Skyward Specialty Insurance Group, Inc. had $1.4B of revenue in fiscal 2025, up 23.2% on the year before.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew 36.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $403M in fiscal 2025, 28.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Skyward Specialty Insurance Group, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 1.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Skyward Specialty Insurance Group, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $42.1M | $45.4M | $65.9M | $122M | $169M |
| Total assets | $2.1B | $2.4B | $3.0B | $3.7B | $4.8B |
| Total liabilities | $1.7B | $1.9B | $2.3B | $2.9B | $3.8B |
| Shareholders' equity | $426M | $422M | $661M | $794M | $1.0B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β6.5% | β7.6% | β9.5% | β5.6% | β5.6% |
| Altman Z'' | β | β | β | β | β |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $550M | $642M | $886M | $1.2B | $1.4B |
| Noninterest income | β | β | $6.1M | $6.7M | $6.9M |
| Interest expense | $4.6M | $6.4M | $10.0M | $9.5M | $7.9M |
| Pretax income | $48.3M | $49.8M | $110M | $153M | $216M |
| Income tax | $10.0M | $10.4M | $24.1M | $33.9M | $46.4M |
| Net income | $38.3M | $39.4M | $86.0M | $119M | $170M |
| Net income to common | $19.8M | $20.5M | $84.3M | $119M | $170M |
| Diluted EPS | $1.18 | $1.21 | $2.24 | $2.87 | $4.07 |
| Diluted shares | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B |
| Cash flow | |||||
| Cash from operations | $175M | $209M | $338M | $305M | $408M |
| Capital expenditure | $2.2M | $2.3M | $3.1M | $4.2M | $5.5M |
| Free cash flow | $173M | $207M | $335M | $301M | $403M |
| Depreciation and amortization | $5.6M | $4.1M | $3.9M | $3.4M | $3.5M |
| Stock-based compensation | $0.5M | $2.3M | $8.5M | $9.4M | $12.0M |
| Balance sheet | |||||
| Cash and short-term investments | $42.1M | $45.4M | $65.9M | $122M | $169M |
| Property and equipment, net | $9.6M | $8.7M | $9.1M | $12.2M | $15.1M |
| Goodwill | $65.7M | $65.7M | $65.7M | $65.7M | $65.7M |
| Intangible assets | $25.6M | $24.1M | $22.7M | $21.6M | $22.3M |
| Total assets | $2.1B | $2.4B | $3.0B | $3.7B | $4.8B |
| Total liabilities | $1.7B | $1.9B | $2.3B | $2.9B | $3.8B |
| Preferred stock | $0.0M | $0.0M | $0.0M | β | β |
| Shareholders' equity | $426M | $422M | $661M | $794M | $1.0B |
| Margins | |||||
| Net margin | 7.0% | 6.1% | 9.7% | 10.3% | 12.0% |
| FCF margin | 31.5% | 32.2% | 37.8% | 26.2% | 28.4% |
| Returns | |||||
| Return on equity | 9.0% | 9.3% | 15.9% | 16.3% | 18.9% |
| Return on assets | 1.8% | 1.8% | 3.2% | 3.6% | 4.0% |
| Return on tangible equity | 5.9% | 6.2% | 14.7% | 16.8% | 18.5% |
| Growth | |||||
| Revenue growth | β | 16.8% | 37.9% | 29.8% | 23.2% |
| Net income growth | β | 2.8% | 118.3% | 38.2% | 43.1% |
| EPS growth | β | 2.5% | 85.1% | 28.1% | 41.8% |
| FCF growth | β | 19.3% | 62.2% | β10.2% | 33.8% |
| Share count change | β | 0.6% | 17.3% | 8.0% | 1.0% |
| Capital allocation | |||||
| Capex / revenue | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Stock comp / revenue | 0.1% | 0.4% | 1.0% | 0.8% | 0.8% |
| Quality scores | |||||
| Accruals ratio | β6.5% | β7.6% | β9.5% | β5.6% | β5.6% |
Source: SEC EDGAR XBRL filings (CIK 0001519449). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.